Uncategorized

A focus on core leverage at IBM

admin | January 24, 2020

This document is intended for institutional investors and is not subject to all of the independence and disclosure standards applicable to debt research reports prepared for retail investors. This material does not constitute research.

While IBM continues to trade wide to its single A technology peers, bonds could begin to collapse closer to peers as 4Q results suggest the company is turning a corner with respect to revenue growth and management remains focused on debt reduction.

IBM’s (A2/A) credit curve is shown relative to Oracle Corp.’s (ORCL – A1/A+ (n)/A) (Exhibit 1). ORCL has spent the larger part of the past three years reducing its sizeable cash position to fund a hefty share buyback program, moving from a net cash position to a net debt position. Adjusted leverage, as per S&P’s calculations, is expected to climb to the 2.0x area by fiscal year-end 2020 (May 2020), up from 1.4x in the year-ago period. S&P has also noted that management’s lack of a clear financial policy underscores its current negative outlook and indicates that there is a one in three chance that they downgrade the rating over the next two years. This is the opposite of IBM’s financial policy which has suspended its share repurchase program to accelerate debt reduction post its acquisition of Red Hat. IBM’s focus on debt reduction and leverage seems to be better reflected in the CDS market, as IBM 5-year CDS currently trades 6 bp through ORCL 5-year CDS. ORCL’s CDS has slowly been drifting wider since July 2019, while IBM’s CDS has reached a 52 week low (Exhibit 2).

Exhibit 1: IBM vs ORCL credit curves

Source: Bloomberg

Core leverage within rating agencies’ expectations

IBM reduced debt by $3.4 billion in 4Q, putting total debt reduction at $10 billion since the close of the Red Hat acquisition in June 2019. Total debt at year-end 2019 stood at $63 billion, of which $38 billion is related to the core business and $25 billion is global financing debt. Total leverage currently stands at 3.6x while core leverage is over a turn lower at roughly 2.3x. While total leverage is optically high for the current ratings A2/A ratings profile, the rating agencies focus on the core leverage ratio for ratings purposes. That said, for comparison purposes investors can consider core leverage relative to peers.

Exhibit 2: IBM vs ORCL 5-year CDS (1/23/19 – 1/20/20)

Source: Bloomberg

Based on the current pace of debt reduction, management noted on its earnings call that they are on track to achieve a leverage ratio consistent with a mid-to-high single A rating in a couple of years. Both Moody’s and S&P are targeting core leverage of 2.0x within 18-24 months from the close of Red Hat for the current ratings. Based on current fiscal 2020 guidance of free cash flow (before dividends) of $12.5 billion, we estimate that IBM has roughly $6.7 billion that it could put towards debt reduction in 2020. This would put core leverage at 1.8x by year end 2020 (assuming no EBITDA growth).

Maturity profile supports debt reduction

IBM’s debt maturity schedule lends to further deleveraging over the next couple of years as IBM has over $6 billion of debt maturing per year for the next three years. This alleviates the need to tender for bonds, which could prove costly and does not guarantee that investors participate. Furthermore, IBM has very little outstanding high coupon debt that it hasn’t already targeted, with the exception of the 7% 2025 bonds ($600 million outstanding). IBM is expected to issue debt selectively as free cash flow (less dividends) does not fully cover all debt maturing over the next three years ($22.6 billion).

Exhibit 3. IBM debt maturity schedule ($ in millions)

Source: Bloomberg

4Q operating highlights

IBM posted solid 4Q19 results which were underscored by positive sales growth. Revenues for the quarter were up 3% (ex fx), marking its first quarter of positive sales growth since 2Q18. Growth was fueled by strong double digit performance at newly acquired Red Hat, which posted organic revenue growth of 24% in the quarter. This enabled the Cloud & Cognitive Services business, IBM’s second largest business unit in terms of sales, to post strong revenue growth of 9.4% (ex fx) for the quarter. Investments in higher margin businesses helped position the company for strong gross margin performance. Adjusted growth margin in the quarter expanded 230 bp year-over-year (to 51.8%). Higher RD&E and SG&A spending, primarily relating to its z15 mainframe launch, impacted growth on the EBITDA line. IBM’s adjusted EBITDA margin for the quarter was 28%, up 10 bp year-over-year.

admin
jkillian@apsec.com
john.killian@santander.us 1 (646) 776-7714

This material is intended only for institutional investors and does not carry all of the independence and disclosure standards of retail debt research reports. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.

This message, including any attachments or links contained herein, is subject to important disclaimers, conditions, and disclosures regarding Electronic Communications, which you can find at https://portfolio-strategy.apsec.com/sancap-disclaimers-and-disclosures.

Important Disclaimers

Copyright © 2024 Santander US Capital Markets LLC and its affiliates (“SCM”). All rights reserved. SCM is a member of FINRA and SIPC. This material is intended for limited distribution to institutions only and is not publicly available. Any unauthorized use or disclosure is prohibited.

In making this material available, SCM (i) is not providing any advice to the recipient, including, without limitation, any advice as to investment, legal, accounting, tax and financial matters, (ii) is not acting as an advisor or fiduciary in respect of the recipient, (iii) is not making any predictions or projections and (iv) intends that any recipient to which SCM has provided this material is an “institutional investor” (as defined under applicable law and regulation, including FINRA Rule 4512 and that this material will not be disseminated, in whole or part, to any third party by the recipient.

The author of this material is an economist, desk strategist or trader. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM or any of its affiliates may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.

This material (i) has been prepared for information purposes only and does not constitute a solicitation or an offer to buy or sell any securities, related investments or other financial instruments, (ii) is neither research, a “research report” as commonly understood under the securities laws and regulations promulgated thereunder nor the product of a research department, (iii) or parts thereof may have been obtained from various sources, the reliability of which has not been verified and cannot be guaranteed by SCM, (iv) should not be reproduced or disclosed to any other person, without SCM’s prior consent and (v) is not intended for distribution in any jurisdiction in which its distribution would be prohibited.

In connection with this material, SCM (i) makes no representation or warranties as to the appropriateness or reliance for use in any transaction or as to the permissibility or legality of any financial instrument in any jurisdiction, (ii) believes the information in this material to be reliable, has not independently verified such information and makes no representation, express or implied, with regard to the accuracy or completeness of such information, (iii) accepts no responsibility or liability as to any reliance placed, or investment decision made, on the basis of such information by the recipient and (iv) does not undertake, and disclaims any duty to undertake, to update or to revise the information contained in this material.

Unless otherwise stated, the views, opinions, forecasts, valuations, or estimates contained in this material are those solely of the author, as of the date of publication of this material, and are subject to change without notice. The recipient of this material should make an independent evaluation of this information and make such other investigations as the recipient considers necessary (including obtaining independent financial advice), before transacting in any financial market or instrument discussed in or related to this material.